NCI, Inc. (NCIT) CEO Clark Resigns; Successor Named
- Wall St. set to rise ahead of Trump inauguration
- General Electric (GE) Reports In-Line Q4 EPS
- Procter & Gamble (PG) Tops Q2 EPS by 2c
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Dollar recoups losses, caution sets in ahead of Trump inauguration
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
NCI, Inc. (Nasdaq: NCIT) announced that its board of directors has appointed Paul A. Dillahay as president and chief executive officer, effective immediately. Mr. Dillahay replaces Brian J. Clark, who resigned as president and chief executive officer and a director of NCI, to pursue other opportunities. Mr. Dillahay previously held the position of executive vice president of CACI International’s Health and Litigation Solutions group. Mr. Dillahay also was appointed to NCI’s board of directors.
Mr. Dillahay has proven industry leadership in executing transformational change initiatives, developing leaders and delivering sustainable results. In addition to CACI, he spent the past 15 years in senior management positions at General Electric, Lockheed Martin, US Investigation Services (USIS) and ASRC Federal.
Mr. Dillahay has delivered exceptional results in various leadership roles at Lockheed Martin, including leading the Operation Support business within the Information Systems and Global Solutions division. After leaving Lockheed Martin in 2010, he joined USIS as chief operating officer. He then joined ASRC Federal as chief operating officer and was promoted to president and chief executive officer in 2013. Mr. Dillahay joined CACI in 2016 as executive vice president for corporate development, supporting the company’s strategic focus on mergers and acquisitions to drive growth, before assuming his most recent role.
“On behalf of the board of directors, I thank Brian for his service to NCI in right sizing the infrastructure and building a strong balance sheet,” said Charles K. Narang, chairman of the board of NCI. “I look forward to working with Paul. I think his background and experience will be a tremendous benefit to the company going forward.”
Mr. Dillahay commented: “I'm excited about the opportunity to lead NCI into the future, work with the board and the leadership team, and expand on NCI's commitment to our customers and employees. NCI's culture of trust, integrity and performance is a tremendous foundation to build upon as we seek to create sustainable organic growth, while delivering shareholder value.”
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sonic Corp (SONC) Elects Steven Davis to Board of Directors
- PPG Industries (PPG) Names Vincent Morales to CFO
- Ethicon Announces Acquisition of Megadyne Medical Products (JNJ)
Create E-mail Alert Related CategoriesManagement Changes, Management Comments
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!